Furthermore, mechanistic studies revealed that VAV3 knockdown could dysregulate the expression and activities of metastasis-related molecules by inhibiting the PI3K-AKT signaling pathway in both CRC cells and xenografts. This evidence concerns the gene VAV3 and colorectal carcinoma.